Spondyloarthritis

EULAR/PReS Standards for Transitional Care of Juvenile-Onset Rheumatic Diseases

Panel advises that up to 50% of young patients with juvenile-onset rheumatic diseases fail to successfully transition to adult rheumatology services.

Clinician Roundtable: Effective Management of Noninfectious Uveitis

Autoimmune uveitis is usually a diagnosis of exclusion. Part of the challenge of effective management of noninfectious uveitis is that it is not really a ...

Video Review: Differentiating Septic and Reactive Arthritis

Seronegative spondyloarthropathies associated with human leukocyte antigen (HLA) B27 antigens can manifest as an acute inflamed joint and must be differentiated from septic arthritis.

Lead Investigator Discusses Phase 3 Trial of IL-17A Inhibitor in PsA

Philip Mease, MD, clinical professor, University of Washington School of Medicine, Seattle, discusses the treatment of psoriatic arthritis (PsA) by inhibiting interleukin (IL)-17A with the ...

When Should Rheumatologists Refer Patients for Evaluation by an Orthopedic Surgeon?

Michael M. Alexiades, MD, met with Rheumatology Advisor to discuss the timely referral of patients with inflammatory arthritides who may be candidates for operative intervention.

Evaluation of the Pediatric Patient With Joint Pain and Swelling

Watch a video providing a comprehensive review of the distinguishing factors between the presentation of septic arthritis and Lyme arthritis.

VIDEO: Discussing the Use of Biosimilars for Rheumatic Disease

Discussion of the recent introduction of biosimilar agents into the treatment armamentarium for rheumatic disease.

Delayed Recognition of Spondyloarthritis: Diagnostic Challenges & Opportunities

Delayed diagnosis is associated with worse outcomes and poor treatment responses in patients with spondyloarthritis. Andrew Vreede, MD, University of Wisconsin School of Medicine and ...

Looking Beyond Corticosteroids to Treat Noninfectious Uveitis

The recent US Food and Drug Administration (FDA) approval of adalimumab (Humira®, AbbVie) for the treatment of noninfectious intermediate, posterior, and pan-uveitis is the first ...

Looking Beyond Traditional CV Risk Factors to Predict CV Events in PsA

In addition to traditional cardiovascular risk factors, increased PsA disease activity also appears to increase cardiovascular risk.

Latest News

Ankylosing Spondylitis Etanercept May Increase Risk of Anterior Uveitis in Ankylosing Spondylitis

Etanercept May Increase Risk of Anterior Uveitis in Ankylosing Spondylitis

Researchers examined whether different TNF inhibitors were associated with different rates of anterior uveitis in patients with ankylosing spondylitis undergoing treatment with adalimumab, etanercept, or infliximab.

Psoriatic Arthritis Psoriatic Arthritis Development Predicted by Musculoskeletal Symptoms

Psoriatic Arthritis Development Predicted by Musculoskeletal Symptoms

Prospective cohort study of patients with psoriasis who were assessed annually to examine for development of clinical psoriatic arthritis.

Rheumatoid Arthritis High-dose Steroids Increase Serious Infection Risk in Pregnant Women With Inflammatory Conditions

High-dose Steroids Increase Serious Infection Risk in Pregnant Women With Inflammatory Conditions

An observational cohort study of 4961 women with completed pregnancies and a recorded diagnosis of systemic inflammatory conditions.

Rheumatoid Arthritis Minimal Amount of TNF Inhibitor Transfers to Breast Milk, Study Finds

Minimal Amount of TNF Inhibitor Transfers to Breast Milk, Study Finds

Study evaluated breast milk samples from 17 lactating mothers diagnosed with rheumatoid arthritis, Crohn's disease, psoriatic arthritis, and axial spondyloarthritis/ankylosing spondylitis.

Psoriatic Arthritis Secukinumab Efficacy for Psoriasis Examined After Treatment Pause

Secukinumab Efficacy for Psoriasis Examined After Treatment Pause

Findings come from 2 trials; one compared secukinumab with placebo, whereas the other compared secukinumab with placebo and etanercept.

The Handoff The Handoff: Your Week in Rheumatology News - 3/3/17

The Handoff: Your Week in Rheumatology News - 3/3/17

Connecticut considers rheumatoid arthritis and fibromyalgia for medical marijuana treatment, while Lyme disease-carrying deer ticks continue to invade Michigan. All this and more in this week's edition.

Rheumatoid Arthritis Arthritis and Incident Myocardial Infarction Risk

Arthritis and Incident Myocardial Infarction Risk

Research comes from meta-analysis of 25 population-based studies on 5 major forms of arthritis.

Psoriatic Arthritis Depression Significantly Increases Psoriatic Arthritis Risk Among Patients With Psoriasis

Depression Significantly Increases Psoriatic Arthritis Risk Among Patients With Psoriasis

Study evaluated clinical data to determine a possible role of major depressive disorders in the progression of inflammatory disease.

Spondyloarthritis FDA Approves Brodalumab Injection for Plaque Psoriasis Treatment

FDA Approves Brodalumab Injection for Plaque Psoriasis Treatment

Siliq will carry a Black Box Warning and is available only through a restricted program.

The Handoff The Handoff: Your Week in Rheumatology News - 2/17/17

The Handoff: Your Week in Rheumatology News - 2/17/17

Clinical management recommendations for juvenile dermatomyositis, updated guidelines for low back pain treatment, and more of this week's news.

Sign Up for Free e-newsletters